We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
- Authors
Kuukasjärvi, T; Kononen, J; Helin, H; Holli, K; Isola, J
- Abstract
Up to 30% to 40% of metastases from hormone receptor-positive primary breast cancer do not respond to endocrine therapy. We studied how often hormone receptor status changes between primary and recurrent tumors and whether such a change might explain unresponsiveness to endocrine therapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Vol 14, Issue 9, p2584
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1996.14.9.2584